“Protein Predicts Response to New Immunotherapy Drug,” Yale Cancer Center/Smilow Cancer Hospital

The presence of an immune-suppressing protein in non-cancerous immune cells may predict how patients with different types of cancer respond to treatment, a multi-center phase I study using an investigational immune therapy drug has found. The study, led by a Yale Cancer Center investigator, is described in the November 27 edition of the journal Nature. Yale Cancer Center and Smilow Cancer Hospital is one of the 25 NCCN Member Institutions. ...
Source: National Comprehensive Cancer Network - Category: Cancer & Oncology Source Type: news